Why New York Personal Injury Pharmacies Keep Getting Sued

James Wong — Founder & Pharmacist, LienScripts | February 22, 2026 | 10 min read

A wave of federal RICO lawsuits has swept through New York's personal injury pharmacy space, with GEICO, Allstate, and American Transit Insurance filing suits alleging millions in no-fault billing fraud. Here's what's driving the litigation, what the standard fraud playbook looks like, and what it means for attorneys who refer clients to pharmacies.

A Wave of RICO Suits Hits NY Personal Injury Pharmacies

Over the past two years, personal injury pharmacies across New York City have become targets of some of the most aggressive civil fraud litigation in the country. GEICO, Allstate, and American Transit Insurance Company have collectively filed dozens of federal lawsuits — many under the Racketeer Influenced and Corrupt Organizations Act (RICO) — against pharmacies operating in Brooklyn, Queens, and the Bronx.

The cases allege strikingly similar fact patterns: pharmacies embedded in referral networks with no-fault clinics, concentrated billing for a narrow set of cheap topical medications, and financial arrangements with prescribers that prioritize volume over patient care. Damages claimed range from $2.5 million to $6 million per case.

[!KEY] These lawsuits are specifically about New York's no-fault billing system — a direct-payment model that is structurally different from pharmacy lien arrangements. Understanding the distinction helps attorneys evaluate pharmacy partners more accurately.

This post explains the fraud playbook that recurs across these cases, the red flags that trigger RICO exposure, and what the litigation wave means for personal injury attorneys choosing pharmacy partnerships.

Why New York's No-Fault System Creates a Unique Risk Environment

To understand why NY pharmacies keep getting sued, you first have to understand what makes New York's auto insurance system different from most states.

New York is a no-fault state. Every auto policy issued in New York carries a minimum of $50,000 in Personal Injury Protection (PIP) benefits. When a person is injured in an auto accident — regardless of who was at fault — their own insurer must pay their medical bills directly to treating providers, including pharmacies.

This creates a direct billing channel between pharmacies and insurers. A pharmacy that fills prescriptions for an auto accident patient submits claims directly to that patient's PIP carrier. The insurer is legally required to pay within 30 days or face mandatory arbitration before the American Arbitration Association.

This payment structure creates a high-volume, low-oversight billing window that bad actors have systematically exploited. A pharmacy can submit thousands of claims, receive payment within 30 days per claim, and generate millions in revenue before an insurer can investigate or mount a legal challenge.

[!KEY] New York's PIP system is not the same as a pharmacy lien. In the lien model, the pharmacy defers payment entirely until the case settles — there is no direct insurer billing, no fee schedule gaming, and no 30-day payment clock. The fraud dynamics that plague NY no-fault billing simply don't exist in a lien-based pharmacy model.

The Standard Fraud Playbook

A review of federal complaints filed by GEICO and Allstate against multiple NYC pharmacies reveals a remarkably consistent fraud pattern. The core elements appear in case after case:

Step 1: Financial Arrangements With Clinic Insiders

The scheme typically begins with a pharmacy entering into a financial relationship with a clinic controller — the non-physician business operator who manages patient flow at a multidisciplinary no-fault clinic — or with individual nurse practitioners who have prescription authority. These arrangements may involve direct payments, revenue-sharing agreements, or other financial incentives.

The arrangement is structured so that in exchange for financial consideration, the insider steers prescriptions from auto accident patients to the pharmacy.

Step 2: Prescription Steering at the Clinic Level

Patients who come through the no-fault clinic for accident-related care are funneled toward the pharmacy through the established referral arrangement. In multiple GEICO complaints, allegations describe prescriptions written pursuant to predetermined protocols — meaning prescribers issued the same medications to virtually every patient regardless of individual clinical need.

Federal complaints describe this as dispensing drugs "without regard to genuine patient care" and "in accordance with a fraudulent predetermined protocol."

Step 3: Formulary Concentration on High-Margin Topicals

The selected medications are not chosen for clinical efficacy — they are chosen because they are cheap to source but bill at elevated rates under New York's no-fault fee schedule.

In multiple cases, GEICO identified that two or three topical medications accounted for over 80% of all billing submitted by the pharmacy:

• Lidocaine 5% Ointment
• Diclofenac Sodium Gel 3%
• Diclofenac Sodium 2% Solution

A formulary this concentrated — applied uniformly across hundreds of patients with diverse injuries — is a statistical signal that prescribing is protocol-driven rather than clinically individualized. This concentration pattern is one of the primary triggers for RICO investigation.

Step 4: High-Volume Claims Submission

With steering arrangements in place and a concentrated formulary, the pharmacy generates a high volume of nearly identical claims to the insurer. Insurers must pay within 30 days or dispute through arbitration. By the time a pattern is recognized and a RICO complaint is assembled, the insurer may have already paid millions in claims.

[!KEY] In one case, GEICO alleged it had already paid approximately $2.3 million on a single pharmacy's claims before filing suit — with an additional $1.4 million in pending claims still outstanding at the time of filing.

Red Flags That Trigger RICO Exposure

Based on the published complaints, these are the behaviors that consistently appear in pharmacies that end up as RICO defendants:

1. Formulary concentration exceeding ~80% for 2–3 topical medications When the vast majority of a pharmacy's billing consists of the same 2–3 products, insurers treat this as evidence of protocol-driven dispensing rather than individualized care.

2. Financial arrangements with NPs or clinic controllers Direct or indirect payments to prescribers or their affiliated clinic operators, in exchange for prescription referrals, constitute kickbacks under both state and federal law.

3. Co-location in or adjacency to multidisciplinary no-fault clinics Pharmacies physically located in or closely associated with the same building as a no-fault clinic — particularly those that share patient flow — come under heightened scrutiny.

4. "Cookie-cutter" prescriptions across a large patient base If prescribers associated with the pharmacy's referral network consistently issue the same medications to a high percentage of patients, the lack of individualized prescribing becomes a key allegation.

5. Unlicensed individuals with ownership or management control Several complaints identify non-pharmacist owners or managers directing clinical operations — a violation of pharmacy licensing requirements that appears repeatedly in RICO pleadings.

6. Prescriptions described as "illegal, invalid, or unauthorized" Where prescriptions cannot be connected to a valid prescription-prescriber relationship or were issued without genuine examination, insurers allege the underlying prescriptions are invalid — voiding the pharmacy's right to reimbursement.

The Litigation Architecture

GEICO's litigation in this space is largely handled by Rivkin Radler LLP, which has brought dozens of these cases in the Eastern District of New York. The firm has developed a systematic approach: identify the pharmacy, identify the financial relationships, map the prescriber network, and plead RICO conspiracy.

Civil RICO suits are powerful instruments for insurers:

• They allow recovery of treble damages (three times the actual losses) plus attorney's fees
• They permit the insurer to seek a declaratory judgment denying all pending claims while the litigation is pending
• They expose individual pharmacy owners and associates to personal liability alongside the corporate entity
• They can trigger parallel criminal referrals to federal authorities

In addition to GEICO, Allstate has filed mass pharmacy suits — in September 2024 alone, Allstate filed suits against 19 NYC pharmacies in four days, seeking recovery under RICO and common law fraud. American Transit Insurance Company, which specializes in commercial auto coverage for livery vehicles in New York, has also brought state-court fraud actions against pharmacies they allege are part of referral networks with clinics serving their policyholders.

What This Means for Personal Injury Attorneys

If you refer clients to pharmacies for lien-based medication access, the NY no-fault litigation wave contains several practical lessons:

Understand the model your pharmacy partner uses. A pharmacy that bills no-fault insurers directly is operating in a completely different environment than one that defers all payment to settlement through a lien. The fraud dynamics documented in these RICO suits — kickbacks, steering, formulary concentration — are artifacts of the no-fault billing model, not the lien model.

Ask about prescriber relationships. Any pharmacy partner that has financial arrangements with clinic operators or prescribers in exchange for referrals is exposed to the exact liability patterns described in these cases. A compliant pharmacy doesn't pay for prescriptions.

Look at formulary breadth. A legitimate pharmacy serving personal injury patients should be able to fill a wide range of medications across injury types. Extreme concentration in one or two topical compounds is a business model signal, not a clinical one.

Check co-location patterns. A pharmacy physically inside or operationally attached to a single no-fault clinic is likely embedded in the referral network of that clinic. That's a structural conflict of interest.

The NY No-Fault Pharmacy Problem Is Structural

The litigation wave isn't driven by isolated bad actors — it reflects what happens when a regulatory structure creates systematic billing incentives that exceed normal compliance controls. New York's 30-day mandatory payment obligation, combined with high-volume patient flow from staged accidents and legitimate accident claims alike, created an environment where billing fraud could scale faster than insurer oversight.

Pharmacies operating a lien-based model — where payment is deferred entirely until settlement of the underlying claim — aren't billing into this system. The compliance risk profile is fundamentally different.

Related Resources

• New York No-Fault vs. Pharmacy Lien: What PI Attorneys Need to Know
• New York Pharmacy Lien Laws Explained
• How to Evaluate a Pharmacy Lien Provider
• Why Pharmacy Liens Are Challenged and How to Defend Them
• PIP and No-Fault States: Pharmacy Considerations

[!SOURCE] GEICO v. AV Chemists LLC et al., Case 1:24-cv-05110, EDNY — Federal RICO case filed July 2024 in the Eastern District of New York against a Queens-based personal injury pharmacy.

[!SOURCE] NY Department of Financial Services 2024 Health Fraud Annual Report — 41,686 suspected fraud reports received in 2024, the majority involving no-fault claims.